Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A multicenter, randomized, double-blind, placebo-controlled phase II trial
-
Published:2019-03
Issue:3
Volume:70
Page:483-493
-
ISSN:0168-8278
-
Container-title:Journal of Hepatology
-
language:en
-
Short-container-title:Journal of Hepatology
Author:
Hirschfield Gideon M.ORCID,
Chazouillères Olivier,
Drenth Joost P.,
Thorburn Douglas,
Harrison Stephen A.,
Landis Charles S.ORCID,
Mayo Marlyn J.,
Muir Andrew J.,
Trotter James F.,
Leeming Diana J.,
Karsdal Morten A.,
Jaros Mark J.,
Ling Lei,
Kim Kathline H.,
Rossi Stephen J.,
Somaratne Ransi M.,
DePaoli Alex M.,
Beuers UlrichORCID
Funder
NGM Biopharmaceuticals
Cited by
137 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献